Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Non-Current Liabilities (2019 - 2025)

Pulmonx has reported Total Non-Current Liabilities over the past 5 years, most recently at $75.2 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities changed N/A to $75.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $75.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $75.2 million for FY2025, N/A changed from the prior year.
  • Total Non-Current Liabilities was $75.2 million for Q4 2025 at Pulmonx, up from $38.7 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $75.2 million in Q4 2025 and troughed at $38.7 million in Q3 2022.
  • The 3-year median for Total Non-Current Liabilities is $40.5 million (2022), against an average of $47.3 million.